7
Orphan Designations
0
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute lymphoblastic leukemia | A chimeric antigen receptor (CAR) immunotherapy directed against the target protein CD7ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123chimeric Antigen Receptor (CAR) directed against the target protein CD5 | Orphan Designation | - |
| acute myeloid leukemia | Chimeric Antigen Receptor immunotherapy directed against CLL-1 and CD33ICG136:CD123-CD33cCAR T-cells | Orphan Designation | - |
| mature T-cell and NK-cell non-Hodgkin lymphoma | chimeric antigen receptor directed against the target protein CD4 lentivirally transfected T cells | Orphan Designation | - |
| plasma cell myeloma | lentiviral transfected chimeric antigen receptor T-cells modified to target B-cell maturation antigen and CS1 | Orphan Designation | - |